AU2003297235A1 - Anti-infectives - Google Patents

Anti-infectives

Info

Publication number
AU2003297235A1
AU2003297235A1 AU2003297235A AU2003297235A AU2003297235A1 AU 2003297235 A1 AU2003297235 A1 AU 2003297235A1 AU 2003297235 A AU2003297235 A AU 2003297235A AU 2003297235 A AU2003297235 A AU 2003297235A AU 2003297235 A1 AU2003297235 A1 AU 2003297235A1
Authority
AU
Australia
Prior art keywords
infectives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003297235A
Other languages
English (en)
Other versions
AU2003297235A8 (en
Inventor
Duke M. Fitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2003297235A1 publication Critical patent/AU2003297235A1/en
Publication of AU2003297235A8 publication Critical patent/AU2003297235A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2003297235A 2002-12-17 2003-12-11 Anti-infectives Abandoned AU2003297235A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43422702P 2002-12-17 2002-12-17
US60/434,227 2002-12-17
PCT/US2003/040133 WO2004058150A2 (fr) 2002-12-17 2003-12-11 Anti-infectieux

Publications (2)

Publication Number Publication Date
AU2003297235A1 true AU2003297235A1 (en) 2004-07-22
AU2003297235A8 AU2003297235A8 (en) 2004-07-22

Family

ID=32682012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003297235A Abandoned AU2003297235A1 (en) 2002-12-17 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003297235A1 (fr)
WO (1) WO2004058150A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
ES2327764T3 (es) 2004-08-23 2009-11-03 F. Hoffmann-La Roche Ag Compuestos heterociclicos antiviricos.
WO2006066748A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de tetraline et d'indane et utilisations de ceux-ci en tant qu'antagonistes de la 5-ht
WO2006093801A1 (fr) 2005-02-25 2006-09-08 Abbott Laboratories Derives de thiadiazine utiles en tant qu’agents anti-infectieux
CN101189230A (zh) 2005-05-04 2008-05-28 弗·哈夫曼-拉罗切有限公司 抗病毒的杂环化合物
WO2007051735A1 (fr) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Dérivés d'indolylmaléimide en tant qu'inhibiteurs de protéine kinase
JP2009526808A (ja) 2006-02-17 2009-07-23 エフ.ホフマン−ラ ロシュ アーゲー 抗ウイルス性複素環化合物
CN101472884A (zh) 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其用途
JP2009541249A (ja) 2006-06-20 2009-11-26 エフ.ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
BRPI0713502A2 (pt) 2006-06-20 2012-03-13 F. Hoffmann-La Roche Ag derivados de tetralina de arilsulfonamidil e empregos destes
RS51643B (en) 2006-10-10 2011-10-31 Medivir Ab. INHIBITOR HCV NUKLEOZIDA
BRPI1016266A2 (pt) 2009-03-06 2019-09-24 Hoffmann La Roche compostos antivirais heterocíclicos
WO2010122082A1 (fr) 2009-04-25 2010-10-28 F. Hoffmann-La Roche Ag Composes antiviraux heterocycliques
WO2010149598A2 (fr) 2009-06-24 2010-12-29 F. Hoffmann-La Roche Ag Compose antiviral heterocyclique
CA2768924A1 (fr) 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Composes antiviraux heterocycliques
JP2013511489A (ja) 2009-11-21 2013-04-04 エフ.ホフマン−ラ ロシュ アーゲー 複素環式抗ウイルス化合物

Also Published As

Publication number Publication date
WO2004058150A3 (fr) 2006-03-30
AU2003297235A8 (en) 2004-07-22
WO2004058150A2 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003248566A1 (en) Novel anti-infectives
AU2003300957A1 (en) Anti-infectives
AU2003297235A1 (en) Anti-infectives
AU2003300956A1 (en) Anti-infectives
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2002344387A1 (en) Multifunction-pillow
AU2002100026A4 (en) Disc400
AU2002100031A4 (en) earliPay
AU2002100541A4 (en) Backmate
AU2002100602A4 (en) Bonsystem
AU2002100655A4 (en) Armamulch
AU2002100739A4 (en) Neuramax
AU2002100747A4 (en) Powersell
AU2002100957A4 (en) Sluggit
AU2002100160A4 (en) Oxidirator
AU2002100280A4 (en) Proshoe
AU2002100508A4 (en) Photocard
AU2002100510A4 (en) Bottlenecker
AU2002100468A4 (en) Flexi-edger
AU2002100498A4 (en) Linline

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase